UniProt P11473
Vitamin D3 receptor (P11473)
Vitamin D3 receptor (UniProt P11473): 96 experimental structures on GenesisL1, 3 ligands bound, 2 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P11473
- Protein
- Vitamin D3 receptor
- Experimental structures
- 96
- Predicted models
- 0
- Ligands
- 3
- Pockets
- 2 · 1 record with a druggable one
Structures
96 records of P11473 in the MolNFT archive: 96 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1DB1 | Crystal structure of the nuclear receptor for vitamin D complexed to vitamin D | x-ray diffraction | A | — | — |
| 1DB1 | Crystal structure of the nuclear receptor for vitamin D complexed to vitamin D | x-ray diffraction | A | — | — |
| 1IE8 | Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to KH1060 | x-ray diffraction | A | — | — |
| 1IE8 | Crystal structure of the nuclear receptor for vitamin D ligand binding domain bound to KH1060 | x-ray diffraction | A | — | — |
| 1IE9 | Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to MC1288 | x-ray diffraction | A | — | — |
| 1IE9 | Crystal structure of the nuclear receptor for vitamin D ligand binding domain bound to MC1288 | x-ray diffraction | A | — | — |
| 1KB2 | Crystal Structure of VDR DNA-binding Domain Bound to Mouse Osteopontin (SPP) Response Element | x-ray diffraction | A, B | — | — |
| 1KB2 | Crystal structure of vdr DNA-binding domain bound to mouse osteopontin (spp) response element | x-ray diffraction | A, B | — | — |
| 1KB4 | Crystal Structure of VDR DNA-binding Domain Bound to a Canonical Direct Repeat with Three Base Pair… | x-ray diffraction | A, B | — | — |
| 1KB4 | Crystal structure of vdr DNA-binding domain bound to a canonical direct repeat with three base pair… | x-ray diffraction | A, B | — | — |
| 1KB6 | Crystal Structure of VDR DNA-binding Domain Bound to Rat Osteocalcin (OC) Response Element | x-ray diffraction | A, B | — | — |
| 1KB6 | Crystal structure of vdr DNA-binding domain bound to rat osteocalcin (oc) response element | x-ray diffraction | A, B | — | — |
| 1S0Z | Crystal structure of the VDR LBD complexed to seocalcitol. | x-ray diffraction | A | — | — |
| 1S0Z | Crystal structure of the vdr lbd complexed to seocalcitol. | x-ray diffraction | A | — | — |
| 1S19 | Crystal structure of VDR ligand binding domain complexed to calcipotriol. | x-ray diffraction | A | — | — |
| 1S19 | Crystal structure of vdr ligand binding domain complexed to calcipotriol. | x-ray diffraction | A | — | — |
| 1TXI | Crystal structure of the vdr ligand binding domain complexed to TX522 | x-ray diffraction | A | — | — |
| 1TXI | Crystal structure of the vdr ligand binding domain complexed to TX522 | x-ray diffraction | A | — | — |
| 1YNW | Crystal Structure of Vitamin D Receptor and 9-cis Retinoic Acid Receptor DNA-Binding Domains Bound… | x-ray diffraction | A | — | — |
| 1YNW | Crystal structure of vitamin D receptor and 9-cis retinoic acid receptor DNA-binding domains bound… | x-ray diffraction | A | — | — |
| 2HAM | Crystal structure of VDR LBD complexed to 2alpha-propyl-calcitriol | x-ray diffraction | A | — | — |
| 2HAM | Crystal structure of vdr lbd complexed to 2ALPHA-propyl-calcitriol | x-ray diffraction | A | — | — |
| 2HAR | Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol | x-ray diffraction | A | — | — |
| 2HAR | Crystal structure of vdr lbd in complex with 2 alpha-(3-hydroxy-1- propoxy) calcitriol | x-ray diffraction | A | — | — |
| 2HAS | Crystal structure of VDR LBD in complex with 2alpha-(1-propoxy) calcitriol | x-ray diffraction | A | — | — |
| 2HAS | Crystal structure of vdr lbd in complex with 2ALPHA-(1-propoxy) calcitriol | x-ray diffraction | A | — | — |
| 2HB7 | Crystal structure of VDR LBD in complex with 2alpha(3-hydroxy-1-propyl) calcitriol | x-ray diffraction | A | — | — |
| 2HB7 | Crystal structure of vdr lbd in complex with 2ALPHA(3-hydroxy-1- propyl) calcitriol | x-ray diffraction | A | — | — |
| 2HB8 | Crystal structure of VDR LBD in complex with 2alpha-methyl calcitriol | x-ray diffraction | A | — | — |
| 2HB8 | Crystal structure of vdr lbd in complex with 2ALPHA-methyl calcitriol | x-ray diffraction | A | — | — |
| 3A2I | Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with… | x-ray diffraction | A | — | — |
| 3A2I | Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with… | x-ray diffraction | A | — | — |
| 3A2J | Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed… | x-ray diffraction | A | — | — |
| 3A2J | Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed… | x-ray diffraction | A | — | — |
| 3A3Z | Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound… | x-ray diffraction | X | — | — |
| 3A3Z | Crystal structure of the human vdr ligand binding domain bound to the synthetic agonist compound… | x-ray diffraction | X | — | — |
| 3A40 | Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound… | x-ray diffraction | X | — | — |
| 3A40 | Crystal structure of the human vdr ligand binding domain bound to the synthetic agonist compound… | x-ray diffraction | X | — | — |
| 3A78 | Crystal structure of the human VDR ligand binding domain bound to the natural metabolite… | x-ray diffraction | A | — | — |
| 3A78 | Crystal structure of the human vdr ligand binding domain bound to the natural metabolite… | x-ray diffraction | A | — | — |
| 3AUQ | Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene… | x-ray diffraction | A | — | — |
| 3AUQ | Crystal structure of the human vitamin D receptor ligand binding domain complexed with yne-diene… | x-ray diffraction | A | — | — |
| 3AUR | Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene… | x-ray diffraction | A | — | — |
| 3AUR | Crystal structure of the human vitamin D receptor ligand binding domain complexed with yne-diene… | x-ray diffraction | A | — | — |
| 3AX8 | Crystal structure of the human vitamin D receptor ligand binding domain complexed with… | x-ray diffraction | A | — | — |
| 3AX8 | Crystal structure of the human vitamin D receptor ligand binding domain complexed with… | x-ray diffraction | A | — | — |
| 3AZ1 | Crystal Structure Analysis of Vitamin D receptor | x-ray diffraction | A | — | — |
| 3AZ1 | Crystal structure analysis of vitamin D receptor | x-ray diffraction | A | — | — |
| 3AZ2 | Crystal Structure Analysis of Vitamin D receptor | x-ray diffraction | A | — | — |
| 3AZ2 | Crystal structure analysis of vitamin D receptor | x-ray diffraction | A | — | — |
| 3AZ3 | Crystal Structure Analysis of Vitamin D receptor | x-ray diffraction | A | — | — |
| 3AZ3 | Crystal structure analysis of vitamin D receptor | x-ray diffraction | A | — | — |
| 3B0T | Human VDR ligand binding domain in complex with maxacalcitol | x-ray diffraction | A | — | — |
| 3B0T | Human vdr ligand binding domain in complex with maxacalcitol | x-ray diffraction | A | — | — |
| 3CS4 | Structure-based design of a superagonist ligand for the vitamin D nuclear receptor | x-ray diffraction | A | — | — |
| 3CS4 | Structure-based design of a superagonist ligand for the vitamin D nuclear receptor | x-ray diffraction | A | — | — |
| 3CS6 | Structure-based design of a superagonist ligand for the vitamin D nuclear receptor | x-ray diffraction | A | — | — |
| 3CS6 | Structure-based design of a superagonist ligand for the vitamin D nuclear receptor | x-ray diffraction | A | — | — |
| 3KPZ | Crystal structure of a novel vitamin D3 analogue, ZK203278 showing dissociated profile | x-ray diffraction | A | — | — |
| 3KPZ | Crystal structure of a novel vitamin D3 analogue, ZK203278 showing dissociated profile | x-ray diffraction | A | — | — |
36 records more on the page itself.
Ligands
- 8VM · 5-(3-{4-[(2S)-2-hydroxy-3,3-dimethylbutoxy]-3-methylphenyl}pentan-3-yl)-3-methyl-N-(1H-tetrazol-5-yl)thiophene-2-carboxamide · in 2 records
- 90L · (1R,2R,3R)-5-[(E)-2-[(1r,3as,7ar)-7A-methyl-1-[(2R)-6-methyl-6-oxidanyl-heptan-2-yl]-1,2,3,3A,6,7-hexahydroinden-4-yl]ethenyl]-2-(3-oxidanylpropyl) cyclohex-4-ene-1,3-diol · in 1 record
- 90O · (1R,2S,3R)-5-[(E)-2-[(1r,3as,7ar)-7A-methyl-1-[(2R)-6-methyl-6-oxidanyl-heptan-2-yl]-1,2,3,3A,6,7-hexahydroinden-4-yl]ethenyl]-2-(3-oxidanylpropyl) cyclohex-4-ene-1,3-diol · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.